Revolutionize Your Cell Therapy Workflow with Kryogene™ – The Future of Cryopreservation
Revolutionize Your Cell Therapy Workflow with Kryogene™ – The Future of Cryopreservation
Blog Article
Are you struggling with inconsistent cell recovery rates or worrying about compromising cell viability during cryopreservation? You’re not alone. In cell therapy, every step matters—especially when freezing precious cells like CAR-T, NK, or MSCs. That’s where Kryogene™ Cell Freezing Media-CGT by Kryogene (a subsidiary of MileCell Bio) comes in.
Why Choose Kryogene™ for Your Cryopreservation Needs?
Clinically Tested & Compliant: FDA DMF 040563-registered and GMP-certified, our media meets global standards for safety and quality.
l Animal-Free Formula: Say goodbye to animal-derived materials. Our unique, animal-free formulation preserves cell integrity without harmful residues.
l Broad Compatibility: Perfectly suited for CAR-T, NK, γδT, TILs, and mesenchymal stem cells—whether you’re working with fresh isolates or expanded cell populations.
l Proven Performance: Backed by rigorous testing against industry leaders, Kryogene™ ensures ≥97% cell recovery and maintains critical functions like cytokine secretion, differentiation potential, and phenotype specificity.
Real-World Results Speak Volumes:
CAR-T Cells: Comparable recovery rates and CAR expression to leading competitors, even at high densities.
l NK Cells: Exceptional cytotoxic activity post-thaw, supporting robust immunotherapy applications.
l iPSCs & MSCs: Preserves stemness markers and differentiation potential for regenerative medicine.
Simplify Your Workflow:
Our ready-to-use, single-dose system eliminates the hassle of mixing components. With ultra-low endotoxin (<0.5 EU/mL) and no microbial contaminants, Kryogene™ minimizes risk and streamlines your process. Report this page